Ursa showing brisk monthly sales

Published: 2004-03-08 06:57:00

Updated: 2004-03-08 06:57:00

Daewoong Pharm said recently that Ursa (ursodeoxycholic acid; UDCA) capsule, which has been locally recognized as one of the most popular liver protectives for the past 40 years, has witnessed bigger monthly sales of 3.3 billion won in February than the previous year, and the company is expected to target 50.0 billion won in the 2004 sales.

In situation where the total number of liver-relate...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.